SFX by Ex Libris Inc.

Title:	A newly identified c.1824_1828dupATACG mutation in exon 13 of the GAA gene in infantile-onset glycogen storage disease type II (Pompe disease)
Source:	Molecular Biology Reports [0301-4851] Aryani, Omid yr:2014

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hale, S. "The Pompe disease experience in Washington State: Epidemiology, clinical comparisons and mutation update." Molecular genetics and metabolism 108.2 (2013).
description	2.	Bali, Deeksha S. "Blood-based diagnostic testing for Pompe disease: Consistency between GAA enzyme activity in dried blood spots and GAA gene sequencing results." Muscle & nerve 49.5 (2014): 775-776.
description	3.	Kroos, M. "Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants." Human mutation 33.8 (2012): 1161-1165.
description	4.	Stewart, F. "Genetics and epidemiology of Pompe disease." Clinical therapeutics 32 (2010).
description	5.	Kroos, M. "The genotype-phenotype correlation in Pompe disease." American journal of medical genetics. Part C, Seminars in medical genetics 160.1 (2012): 59-68.
description	6.	Joshi, P. R. R. "Molecular diagnosis of German patients with late-onset glycogen storage disease type II." Journal of inherited metabolic disease 31 Suppl 2.Supplement 2 (2008): 261-5.
description	7.	Fujimoto, S. "A novel mutation of the GAA gene in a patient with adult-onset Pompe disease lacking a disease-specific pathology." Internal Medicine 52.21 (2013): 2461-2464.
description	8.	Andreassen, Christer S. "Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease-a long-term follow-up." Molecular genetics and metabolism 112.1 (2014): 40-43.
description	9.	Pouget, S. "The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease." Revue neurologique 169.8-9 (2013): 595-602.
description	10.	Eto, Y. "THE JAPANESE GUIDELINE FOR DIAGNOSIS AND MANAGEMENT OF GLYCOGEN STORAGE DISEASE TYPE II (POMPE DISEASE)." Clinical therapeutics 32 (2010).
description	11.	Mittag, F. "Use of Support Vector Machines for Disease Risk Prediction in Genome‐Wide Association Studies: Concerns and Opportunities." Human mutation 33.12 (2012): 1708-1718.
description	12.	Burton, Barbara K. "Newborn screening for Pompe disease: an update, 2011." American journal of medical genetics. Part C, Seminars in medical genetics 160.1 (2012): 8-12.
description	13.	Robert J. Mattaliano, Robert J. "New developments in the treatment of Pompe disease." Clinical therapeutics 32 (2010).
description	14.	Ishigaki, K. "High-density CT of muscle and liver may allow early diagnosis of childhood-onset Pompe disease." Brain & development 34.2 (2011): 103-106.
description	15.	L, B. "An overview of enzyme replacement therapy for lysosomal storage diseases." Online journal of issues in nursing 13.1 (2008): 4-.
description	16.	Vorgerd, M. "Adult-onset glycogen storage disease type II: phenotypic and allelic heterogeneity in German patients." Neurogenetics 1.3 (1998): 205-211.
description	17.	Kishnani, Priya S S. "A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease." The Journal of pediatrics 148.5 (2006): 671-676.
description	18.	van den Hout, Ans P. "The Natural Course of Infantile Pompe's Disease: 20 Original Cases Compared With 133 Cases From the Literature." Pediatrics 112.2 (2003): 332-40.
description	19.	Kishnani, Priya S. "The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management." American journal of medical genetics. Part C, Seminars in medical genetics 160.1 (2012): 1-7.
description	20.	Klinge, L. "Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial." Neuromuscular Disorders 15.1 (2004): 24-31.